Show
Sort by
-
- Journal Article
- A1
- open access
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
-
Corneal features in trastuzumab emtansine treatment : not a rare occurrence
-
- Journal Article
- A1
- open access
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
-
- Journal Article
- A1
- open access
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression : identification of a modifier of breast cancer risk at locus 11q22.3
-
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers
-
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients
-
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
-
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
-
Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis
-
Physical activity levels after treatment for breast cancer: one-year follow-up